metoclopramide antibody/antigen (BSA/OVA/KLH conjugated hapten)
anti-metoclopramide antibody and Carrier-coupled antigen/immunogen (hapten-carrier conjugates)
Go to Antibiotics diagnostics products collection >>
Product information
Catalog No. | Description | US $ Price (per mg) |
---|---|---|
GMP-SMT-72-1 | 1. BSA-metoclopramide 2. Anti-metoclopramide mouse monoclonal antibody | $2709.00 |
GMP-SMT-72-2 | 1. OVA-metoclopramide 2. Anti-metoclopramide mouse monoclonal antibody | $2709.00 |
GMP-SMT-72-3 | 1. BSA-metoclopramide 2. Anti-metoclopramide human monoclonal antibody | $2709.00 |
GMP-SMT-72-4 | 1. OVA-metoclopramide 2. Anti-metoclopramide human monoclonal antibody | $2709.00 |
GMP-SMT-72-Ag-1 | BSA-metoclopramide | $756.00 |
GMP-SMT-72-Ag-2 | OVA-metoclopramide | $756.00 |
GMP-SMT-72-Ab-1 | Anti-metoclopramide mouse monoclonal antibody | $1953.00 |
GMP-SMT-72-Ab-2 | Anti-metoclopramide human monoclonal antibody | $1953.00 |
Size: 1mg | 10mg | 100mg
Product Description
BSA-metoclopramide
Cat No. | GMP-SMT-72-Ag-1 |
Bioactivity validation | Competitive immunoassay validation (Competitive ELISA) with hapten-carrier conjugates and anti-Hapten antibody; |
Products description | Competitive immunoassay-validated hapten-carrier conjugates BSA-metoclopramide with anti-Hapten antibody. The hapten hapten-carrier conjugates BSA-metoclopramide had been validated with our anti-Hapten antibody Anti-metoclopramide mouse monoclonal antibody via competitive ELISA test. |
Application | ELISA tests and other immunoassays; Lateral flow immunoassay (LFIA); LTIA Immunonephelometry Time-resolved Fluorescence Immunoassay (TRFIA) |
Formulation & Reconstitution | Lyophilized from GM's Protein Stability Buffer2 (PSB2,Confidential Ingredients) or PBS (pH7.4); For PSB2, reconstituted with 0.9% sodium chloride; For PBS, reconstituted with ddH2O. |
Storage | Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles. |
OVA-metoclopramide
Cat No. | GMP-SMT-72-Ag-2 |
Bioactivity validation | Competitive immunoassay validation (Competitive ELISA) with hapten-carrier conjugates and anti-Hapten antibody; |
Products description | Competitive immunoassay-validated hapten-carrier conjugates OVA-metoclopramide with anti-Hapten antibody. The hapten hapten-carrier conjugates OVA-metoclopramide had been validated with our anti-Hapten antibody Anti-metoclopramide mouse monoclonal antibody via competitive ELISA test. |
Application | ELISA tests and other immunoassays; Lateral flow immunoassay (LFIA); LTIA Immunonephelometry Time-resolved Fluorescence Immunoassay (TRFIA) |
Formulation & Reconstitution | Lyophilized from GM's Protein Stability Buffer2 (PSB2,Confidential Ingredients) or PBS (pH7.4); For PSB2, reconstituted with 0.9% sodium chloride; For PBS, reconstituted with ddH2O. |
Storage | Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles. |
Anti-metoclopramide mouse monoclonal antibody
Cat No. | GMP-SMT-72-Ab-1 |
Host of Antibody | Mouse IgG |
Bioactivity validation | Competitive immunoassay validation (Competitive ELISA) with hapten-carrier conjugates and anti-Hapten antibody; Lateral flow immunoassay (LFIA); |
ELISA IC50 (ppb) | 0.25 |
Products description | The anti-Hapten antibody against hapten metoclopramide had been validated with our hapten hapten-carrier conjugates BSA-metoclopramide via competitive ELISA test. |
Application | ELISA tests and other immunoassays; Lateral flow immunoassay (LFIA); LTIA Immunonephelometry Time-resolved Fluorescence Immunoassay (TRFIA) |
Formulation & Reconstitution | Lyophilized from GM's Protein Stability Buffer2 (PSB2,Confidential Ingredients) or PBS (pH7.4); For PSB2, reconstituted with 0.9% sodium chloride; For PBS, reconstituted with ddH2O. |
Storage | Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles. |
Anti-metoclopramide human monoclonal antibody
Cat No. | GMP-SMT-72-Ab-2 |
Host of Antibody | Human IgG1 |
Bioactivity validation | Competitive immunoassay validation (Competitive ELISA) with hapten-carrier conjugates and anti-Hapten antibody; Lateral flow immunoassay (LFIA); |
ELISA IC50 (ppb) | 0.25 |
Products description | The anti-Hapten antibody against hapten metoclopramide had been validated with our hapten hapten-carrier conjugates BSA-metoclopramide via competitive ELISA test. |
Application | ELISA tests and other immunoassays; Lateral flow immunoassay (LFIA); LTIA Immunonephelometry Time-resolved Fluorescence Immunoassay (TRFIA) |
Formulation & Reconstitution | Lyophilized from GM's Protein Stability Buffer2 (PSB2,Confidential Ingredients) or PBS (pH7.4); For PSB2, reconstituted with 0.9% sodium chloride; For PBS, reconstituted with ddH2O. |
Storage | Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles. |
Reference
Validation Data
Click to get more Data / Case study about the product.
Biomarker Information
. Metoclopramide: A Pharmacological Profile in Veterinary Medicine
Metoclopramide, a benzamide derivative, is a significant pharmaceutical agent utilized in both human and veterinary medicine. In veterinary practice, it serves as an invaluable tool for managing a wide range of gastrointestinal disorders in animals. This section will delve into the pharmacological characteristics and uses of metoclopramide in veterinary medicine.
1.1 Mechanism of Action in Veterinary Application
Metoclopramide exerts its pharmacological effects in veterinary patients by antagonizing dopamine receptors, particularly within the central nervous system. This interaction leads to increased gastrointestinal motility, enhancing coordinated muscular contractions along the gastrointestinal tract. In practical terms, this means metoclopramide is effective in alleviating symptoms such as emesis (vomiting), nausea, and delayed gastric emptying, which are common in veterinary medicine.
1.2 Clinical Indications and Veterinary Use
Metoclopramide finds application in a variety of clinical scenarios in veterinary medicine. It is frequently prescribed for animals suffering from conditions like gastritis, esophageal reflux, parvoviral enteritis, and postoperative ileus. Additionally, metoclopramide may be employed as a part of the management strategy for animals undergoing chemotherapy, helping to control chemotherapy-induced emesis.
1.3 Regulatory Considerations in Veterinary Medicine
The use of metoclopramide in veterinary medicine necessitates careful monitoring and regulatory compliance. This is particularly important because of its potential impact on food safety. Residues of metoclopramide in animal-derived products must be controlled to prevent inadvertent accumulation in the human food chain. Therefore, veterinarians must be diligent in ensuring the safe and appropriate use of this drug in animal patients.
2. Quantification Imperatives: The Rationale for Measuring Metoclopramide Levels
2.1 Precision Dosage Administration
Accurate measurement of metoclopramide levels is imperative for ensuring precise dosage administration in veterinary patients. This precision is crucial for achieving the desired therapeutic outcomes while minimizing the risk of under-dosing or over-dosing, both of which can compromise treatment efficacy.
2.2 Pharmacokinetic Profiling and Therapeutic Efficacy
Systematic measurement of metoclopramide levels provides valuable insights into its pharmacokinetic disposition within the animal's body. This includes understanding how the drug is absorbed, distributed, metabolized, and excreted, which is essential for tailoring treatment regimens to achieve maximum therapeutic impact. Knowledge of metoclopramide's pharmacokinetics can help veterinarians optimize dosing regimens for individual animals, taking into account factors like age, species, and underlying health conditions.
2.3 Adverse Event Mitigation and Safety Augmentation
Routine quantification of metoclopramide levels serves as a proactive measure in preventing potential adverse effects and drug interactions. By closely monitoring metoclopramide concentrations, veterinarians can detect any deviations from the expected range and make timely adjustments to treatment plans, safeguarding the welfare of the veterinary patient.
In conclusion, metoclopramide plays a crucial role in veterinary medicine, particularly in managing gastrointestinal disorders in animals. Its mechanism of action, clinical indications, and regulatory considerations all contribute to its significance. Accurate quantification of metoclopramide levels is essential for optimizing treatment outcomes, ensuring safety, and complying with regulatory standards. Veterinary practitioners should be well-versed in both the pharmacological aspects of metoclopramide and the practical considerations of its use to provide the best care for their animal patients.
About GDU
GDU helps global diagnostic partners in high quality of raw material discovery, development, and application. GDU believes in Protein&antibody Innovation for more reliable diagnostic solutions.